vanilmandelic acid has been researched along with Erythroblastosis Fetalis in 2 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hakulinen, A | 1 |
| Pekkarinen, A | 1 |
| Castrén, O | 1 |
2 other studies available for vanilmandelic acid and Erythroblastosis Fetalis
| Article | Year |
|---|---|
Urinary excretion of vanilmandelic acid of children in normal and certain pathological conditions.
Topics: Adolescent; Age Factors; Asthma; Body Temperature; Child; Child, Preschool; Diabetes Mellitus, Type | 1971 |
Excretion of vanilmandelic acid (VMA) in the third trimester of normal and toxaemic pregnancy and other clinical conditions.
Topics: Adolescent; Adult; Diabetes Mellitus; Erythroblastosis, Fetal; Female; Humans; Mandelic Acids; Norep | 1968 |